Golden Biotechnology Corporation (TPEX:4132)

Golden Biotechnology Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,902	2,523	5,582	8,548	17,123	6,459
Market Cap Growth	48.92%	-54.81%	-34.69%	-50.08%	165.10%	66.72%
Enterprise Value	4,168	2,737	5,514	8,163	17,002	6,556
Last Close Price	24.05	15.16	35.96	55.07	118.65	43.73
PS Ratio	87.51	61.65	88.01	39.24	209.41	72.72
PB Ratio	20.48	8.25	13.88	11.18	16.53	7.34
P/TBV Ratio	24.21	9.10	14.91	11.62	17.00	7.63
EV/Sales Ratio	93.50	66.90	86.93	37.48	207.94	73.81
Debt / Equity Ratio	1.72	1.20	0.68	0.37	0.28	0.29
Asset Turnover	0.08	0.06	0.07	0.17	0.06	0.08
Inventory Turnover	0.89	0.72	0.63	0.60	0.38	0.28
Quick Ratio	0.23	0.64	0.75	1.75	1.79	1.79
Current Ratio	0.54	0.92	1.14	2.28	2.57	2.94
Return on Equity (ROE)	-146.06%	-101.91%	-61.99%	-30.20%	-46.33%	-50.09%
Return on Assets (ROA)	-33.90%	-31.13%	-25.14%	-14.32%	-19.83%	-20.12%
Return on Capital (ROIC)	-35.86%	-33.19%	-26.52%	-15.60%	-21.51%	-21.44%
Return on Capital Employed (ROCE)	-117.60%	-94.80%	-85.30%	-37.00%	-39.40%	-37.00%
Earnings Yield	-8.07%	-14.30%	-6.48%	-3.18%	-2.59%	-6.06%
FCF Yield	-6.13%	-10.47%	-4.95%	-3.04%	-1.21%	-4.17%
Buyback Yield / Dilution	-12.93%	-5.90%	-	-7.36%	-5.40%	-9.32%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.